Design of Enzyme Inhibitors as Drugs
Design of Enzyme Inhibitors as Drugs
复制标题
酶抑制剂药物的设计
DOI:
--
复制
发表时间:
1989
期刊:
影响因子:
--
通讯作者:
T. Steinmetzer
中科院分区:
文献类型:
--
作者:
Anjana Patel;H. Smith;T. Steinmetzer
Introduction to the use of enzyme inhibitors as drugs general approaches to the design of inhibitors inhibitors of the Renin-Angiotens in system enzymes lactamase inhibitors enkephalinase inhibitors as drugs monoamine oxidase inhibitors polyamine oxidase inhibitors new developments in enzyme activated irreversible inhibitors of pyridoxal phosphate-dependent enzymes of therapeutic interest cholinesterase and esterase inhibitors and reactivators of organophosphorus-inhibited esterases inhibitors of enzymes of the arachidonic acid metabolic pathways selective inhibitors of dihydrofolate reductases the antibacterial sulphonamides inhibitors of enzymes of the de novo pyrimidine pathway inhibitors of purine biosynthesis inhibitors of Na+, K+ ATpase inhibitors of steriod biosynthesis inhibitions of enzymes involved in bacterial cell wall synthesis inhibition of proteinases development of selective inhibitors of calmodulin-dependent phosphodiesterase and adenylate cyclase inhibitors of carbonic anhydrase inhibition of intracellular methyl transfer and aminopropyl transfer reactions by analogues of substrates, products, and transition states inhibitors of some other target enzymes as potential clinical agents. Index.